Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

CNS, oncology, complex trials boost INC Research’s Q1 growth

CRO INC Research saw its net service revenue increase by 14.5% to $211.5m in Q1, which was considerably higher than analyst expectations and driven by particularly strong growth in trials around CNS (central nervous system), oncology and other complex therapeutic areas.  

Celgene in $450m deal to commercialise MedImmune's anti-PD-L1 candidate

AstraZeneca has inked a development and commercialisation deal with Celgene for its haematology programmed cell death ligand 1 (PD-L1) candidate, MEDI4736.

LabCorp sees Q1 revenue rise slightly as Covance growth downgraded for FY15

Just two months after Covance shareholders signed off on LabCorp acquiring the company, and all seems to be going according to plan, though financial expectations for the rest of the year were slightly lowered by the diagnostics company.

Dispatches from PCT US

TransCelerate CEO, leaders offer update on industry group’s activities

As 20 of the largest biopharma companies have now joined industry group TransCelerate, the group is beginning to use patient centricity and connectivity to influence the clinical trial environment, CEO Dalvir Gill told attendees at the Partnerships in Clinical Trials Conference on Friday in Boston.

EBG Biosimilars 2015

EGA: Low patient recruitment sends biosimilar trials to Eastern Europe

Reluctant doctors and varying reimbursement policies are affecting biosimilar trial recruitment, experts said at the European Generics Association’s biosimilars conference in London last week.

Medidata chasing an ever-increasing slice of the $2bn EDC market

Medidata has reported its strongest ever quarter and says strategic CRO partnerships and risk-based monitoring offer opportunities to penetrate more of the market.

Key Industry Events